Bluetongue (BT) and African horse sickness (AHS) are considered the most important orbiviral diseases in Southern Africans countries. The general endemic status makes these diseases challenging to be quanti ed in terms of their economic impact. Using country reported data from BT and AHS outbreaks and cases, as well as international trade data, the economic impact of BT and AHS is evaluated on local, regional, and global scales. Local scale impact in the Southern African region is underestimated as shown by the underreporting of BT and AHS. Exceptions occur during epidemic cycles of the diseases and when the diseases impact regional animal movement and global trade, as in the case of AHS in South Africa. While BT is not directly implicated as a signi cant non-tari barrier for regional movement, there are unspeci ed clauses in import permits which refer to the 'OIE listed diseases' and the freedom thereof includes endemic diseases like BT. African horse sickness has a much more tangible regional and global economic impact because of movement restrictions within AHS control zones in South Africa and through international movement of horses from this country.